Company intelligence / Profile preview
Eureka Therapeutics, Inc.
Emeryville, California, United Stateseurekatherapeutics.com ↗
- Ownership
- Private
- Employees
- ~46
- Development stage
- Other
01
Overview
Currently conducting Phase I/II US multi-center clinical trials for ET140203 and ECT204 in patients with advanced hepatocellular carcinoma (HCC)
- Therapeutic areas
- Oncology
- Modalities
- T-cell therapiesImmunotherapies
- Industry
- Biotech
02
Drug pipeline
21 assets20 more assets in the full pipeline.
03
Partnerships
ImugeneNovartis
Beyond the preview
Go deeper on Eureka Therapeutics, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eureka Therapeutics, Inc..